Aims: The dynamics of HIV-1 induced AIDS is attributed to several biological variables, which characterize the stage, virulence and morbidity of the disease. The aim of this research is to use a necessary and sufficient subset of these immunological variables to construct a clinically plausible mathematical model of the patho-physiological dynamics of HIV-1 induced AIDS during the acute and chronic phases. This model incorporates the interactions between uninfected CD4+ T cells, HIV-1 infected CD4+ T cells, HIV-1 virions in the blood plasma, and specific cytotoxic CD8+ T cells. The major objective is to derive mathematical criteria depicting conditions under which the HIV-1 virions can be maintained definitely at the subclinical viral blood plasma level such that the HIV-1 seropositive person does not develop full-blown AIDS. Study Design: The model is based on contemporary published patho-physiological data on acute and clinical chronic phase HIV-1 induced AIDS. These data are meticulously condensed into a clinically plausible four-compartmental mathematical model that incorporates the dynamics and interactions between non-HIV-1 infected CD4+ T lymphocytes. HIV-1 infected lymphocytes, free HIV-1 virions in the blood plasma, and HIV-1 specific cytotoxic CD8+ T lymphocytes. The relevant stoichiometric interaction rate constants, apoptotic rate constants, rate constants for viral recruitment from latent reservoirs, and other relevant parameters are clearly exhibited in the mathematical model. The role of CD4+ T cell-induced syncytia is explicitly incorporated into the HIV-1 virion dynamical equation. Place and Duration of Study: This research was done at Fayetteville State University, North Carolina USA and is sponsored by the FSU Mini-Grant Award and the HBCU Graduate STEM Grant. The research was conducted during the Spring of 2012. Methodology: The deterministic nonlinear HIV-1 AIDS patho-physio-dynamical equations are analyzed using the techniques of dynamical system theory, principles of linearized stability, Hartman-Grobman theory and other relevant mathematical techniques. The clinically desirable equilibrium states are and their local existence and global stability are analyzed. Investigative computer simulations are performed illustrating some physiological outcomes. Results: Mathematical criteria are derived under which the clinically desired outcomes can
Introduction
Human Immunodeficiency Virus (HIV) belongs to a family of ribonucleic (RNA) lenti-viruses. In particular, the epidemiologically common subtype called HIV-1 is implicated for causing the Human Acquired Immunodeficiency Syndrome (AIDS). The pathogenesis of AIDS can be divided into three main phases called the acute phase, the clinical latency phase and the full-blown AIDS phase.
The HIV-1 virion uses the glycoprotein gp120 to locate the CD4 surface molecules and the host cells. By means of CCR5 or CXCR4, the HIV-1 virions fuses to the host cell surfaces and eventually enter the cell. The CD4+ T cells are the major targets for the HIV-1 virions. But macrophages, monocytes, neurons, astrocytes, and microglia cells in the central nervous system (CNS) possess CCR5 chemokine co-receptors and hence are targets of HIV-1 virions. These findings are summarized in [1] [2] [3] . The pathogenesis of HIV-1 infection comprises the virus life cycle, the host cellular environment and the viral load in the infected person. There exist strains of HIV-1 virus known as T-tropic and M-tropic which interact respectively with the CXCR4 and CCR5 chemokine co-receptors.
During the acute phase of HIV-1 infection, the person is seropositive after exposure and immunological reaction to the initial viral inoculum. The person experiences transient infection resembling mononucleosis for 1-12 weeks. The symptomatic primary HIV-1 infection is usually characterized by fever, lymphadenopathy, pharyngitis, arthralgia, rash and lethargy. This is called acute retroviral syndrome (ARS) and is experienced by most but not all of the HIV-1 infected persons. During this phase, large amount of HIV-1 virions are produced inside the patient body. Inside the patient body, the HIV-1 viral envelope decoates and HIV RNA, reverse transcriptase, integrase and other viral protein enter the host cell leading to formation of a pre-integration complex inside the host cell such as the CD4+ T cells. Then reverse transcriptase is used to produce HIV-1 viral DNA. The viral DNA is transported across the nucleus of the host cell and integrates into the host DNA. The next step is the production of new HIV-1 viral proteins using the HIV-1 viral RNA as genomic RNA. HIV proteases cleave newly synthesized polyproteins at the appropriate places to create the mature protein components of an infectious HIV virion. Then the new viral RNA and viral proteins migrate to the host surface and form a new immature HIV1provirus. The mature newly formed HIV-1 virions exit the host cell by a process called budding. In particular, several millions of virus RNA copies may be released into the blood plasma of the patient.
After 3 months, the chronic clinical latency phase starts. During this phase, the rate of HIV-1 replication in the host cell decreases as the CD4+ T cells numbers increases as a result of the cytotoxic intervention of the body's immune system mounted by the CD8+ T cells. In particular, it is possible at this stage for the blood plasma HIV-1 viral titre to be subclinical and plunge to undetectable levels. This may continue up to 8 years or longer, according to the results obtained in [4] [5] [6] [7] .
The third phase of HIV-1 dynamics is characterized by a rapid exponential increase in the number of HIV-1 virions in the blood plasma, increase in the number of HIV-1 infected CD 4 + T cells and a rapid decrease of uninfected CD4+ T cells to a level below 200 cells per microliter and a complete failure of the anti-HIV cytotoxic activity of CD8+ T cells. The details are found in [8, 9] .
Several mathematical models of HIV-1 dynamics have been constructed by many authors in [4, [10] [11] [12] [13] [14] [15] [16] . These authors proposed various mathematical models which describe certain aspects of HIV-1 life cycle with the aim of finding criteria for cure of AIDS or present a quantitative analysis of the dynamics of the HIV-1 virus. Authors in [17] presented a detailed analysis of three different mathematical models with regard to local and global stability of infected and uninfected equilibrium (steady) states of HIV-1 infection. Their analysis also included the dynamics of time delay models. Authors in [18] performed an elaborate analysis of the global dynamics of a mathematical model for HTLV-1 infection of CD4+ T cells with delayed CTL response. In particular, they demonstrated that the time delay can destabilize the system equilibrium leading to Hopf bifurcations and stable periodic oscillations. Similar analysis of the global dynamics of HIV-1 infection of CD4+ T cells was done in [19] . They obtained some interesting results on the stability of infected and non-infected equilibrium states of AIDS infection. A stochastic model for HIV-1 population dynamics has been presented and analyzed in [20] . In particular, they analyzed the random fluctuations associated with HIV-1 infection and dynamics. In the forthcoming paper, we will present a stochastic model of HIV-1 dynamics which incorporates viral contributions from latent reservoirs and also accounts for apoptosis. The interactions of the model equations will incorporate mathematical analogues of the physiological processes suggested in the works published in [5, 8, [21] [22] [23] [24] [25] [26] [27] [28] [29] .
In this paper, new mathematical models for the acute phase and the asymptomatic clinical latency phase are proposed and analyzed. In particular, elaborate and robust mathematical criteria will be presented elucidating the conditions under which the chronic clinical latency phase can be maintained indefinitely in the seropositive HIV-1 infected person.
Definition and Description of Model Parameters
The model of HIV-1 patho-physio-dynamics presented in this paper contains many variables and constant parameters. These parameters include stoichiometric interaction coefficients, cellular degradation rate constants, apoptotic rate constants, rate constants for production of immune cells from the thymus gland via haematopoietic progenitors, rate constants for recruitment of HIV-1 virions from latent reservoirs, intra-specific competition rate constants between infected / uninfected CD4+ T cells, and activation constants for CD4+/CD8+ T cells. The catalogue of constants is presented as follows. 
Model Description and Analysis
In this section, the mathematical formulation for the acute and chronic phase of HIV-1 pathophysio-dynamics will be presented. In describing the model, the activation function is given by the expression:
In particular, this function depicts the process of lymphocyte activation which is mediated by x 1 (CD 4+) helper T cells, where a j , b j are constants associated with activation of lymphocytes by cytokine interleukin-2 (IL-2). These cells secrete a lymphokine called interleukin-2. In the activation process, the a j coefficient is a measure of the duration whereas the b j coefficient modulates the peak of the activation. If j equals to 1, then the interleukin-2 activation of helper T cells x 1 which is represented by ) , (
is an autocrine process; otherwise, the ) ,
activation function depicts a paracrine process for j={ 2,4}.
The Description of the Mathematical Model

The CD4+ T cell dynamics
The instantaneous number of uninfected CD4+ T cells in the blood plasma of the patient at any time during the acute or chronic phase is equal to the rate of supply of uninfected CD4+ T cells ) and less the number of CD4+ T cells lost by apoptosis/exfoliative cytolytic death( 10 e ). The existence of the HIV-1 virion recruitment from the reservoirs as depicted by S 1 explained in [26] . The autocrine activation term of the equation is explained [30] . The apoptotic degradation term of the equation is discussed in [31] .
The HIV-1 infected CD4+ dynamics
The instantaneous number of HIV-1 infected CD4+ T cells in the blood plasma of the patient during the acute or chronic phase is equal to the rate of supply of HIV infected CD4+ T cells from The existence of the reservoirs for latently infected CD4+ T cells as depicted by S 2 term is explained in [32] . The existence of the term
is due to the research data from [8, 23] .
The blood plasma HIV-1 virion dynamics
The instantaneous number of HIV-1 virions in the blood plasma of the patient is equal to the rate virions production in the CD4+ T cells and dissemination into the blood plasma. In particular, it has been demonstrated that HIV-1 induces cell-to-cell fusion with syncytia formation in some AIDS patients. The syncytia conglomerate consists of both infected CD4+ cells and HIV-1 virions, which serve as an HIV-1 disseminating unit by the mechanism of virological synapsemediated cell adhesion and viral endocytosis, as discussed in [33, 34, 35] . These authors concurred that the cell-to-cell-HIV-1 syncytia depicted by ( 
The CD8+ T cells dynamics
The instantaneous number of HIV-1 specific CD8+ T cells is equal to the rate of supply the thymus via hematopoietic progenitor cells; plus activation/proliferative recruitment of antigen activated and interleukin-2 stimulated HIV-1 specific CD8+ T cells ( 
The Cauchy Problem for Dynamics of HIV-1 during the Acute and Chronic Phases
In this section, the initial value problem (Cauchy problem) for HIV-1 dynamics during the acute and chronic phases will be mathematically analyzed and discussed with regard to wellposedness, dissipativity of solutions, and invariance of non-negativity.
From the previous section, the mathematical model for HIV-1 dynamics during the acute and chronic phases can be described in terms of the following deterministic, non-linear and coupled ordinary differential equations. It is assumed that within certain biological limits the environment of the interactions between the uninfected CD4+ T cells, HIV-1 infected CD4+ T cells, HIV-1 virions in the blood plasma, and HIV-1 specific CD8+ T cells is homogeneous, isotropic and hence space independent. Thus ordinary differential equations can be used in the modeling. In the future, mathematical models using partial differential equations, stochastic differential equations, and delay differential equations will be presented. Thus the Cauchy problem is described by the following system of equations: 
Let t 0 be the time of the initial HIV-1 infection; and define t L , t P , repectively, as the time at which the latency phase begins and the time at which the post latency phase of HIV-1 dynamics commences in a patient. In particular, the phases [t 0 , t L ], [t L , t P ] depict respectively the acute phase and the chronic phase of primary HIV-1 induced AIDS.
Dissipativity and Boundedness of Solutions
In this subsection, the dissipativity of the model equations will be discussed.
Definition: Consider the autonomous system of ordinary differential equations:
Then the system (3.6) is dissipative if
In particular, the flow trajectories of the system are asymptotically uniformly bounded. For dissipative systems, the existence of an interior equilibrium is a consequence of uniform persistence, as discussed in [36] [37] [38] . Physiologically, the flow or output of a biological system is dissipative if it is bounded such that the associated flow or output cannot exceed a certain threshold or maximum value. Thus the physiological flow is homeostatically controlled by processes such as cell degradation, exfoliation, apoptosis, loss of clonogenicity and enzymatic/hormonal modulation. This guarantees that the solutions to the system of differential equations of the model are ultimately bounded and exhibit invariance of non-negativity.
The invariance of non-negativity, ultimate boundedness of solutions and dissipativity of the model equations will be shown as follows:
Where t L is the time at which the latency phase begins. Similarly, t P is the time at which the post latency phase of HIV-1 dynamics commences in a patient and the time beyond which full-blown AIDS occurs.
Differential inequalities are constructed in an attempt to obtain upper bounds on the values of x i , i = {1,2,3,4}, based on some critical physiological interactions that affect their dynamics. The processes chosen in this model include the supply rates S i , the IL-2 activation rates , clonogenic biodegradation rates (k i x i ) and apoptotic degradation rates (e i0 ).
The system of differential equations (3.5) reduce to the following differential inequalities,
Using the Kamke comparison technique (see [39] ), the differential inequalities lead to the following theorem. 
Then all solutions of the initial value problem (3.5) that originate in int + 4 will eventually enter the set of A, such that the solution will be non-negative, ultimately bounded and remain in A for all t  + .
Proof
The differential inequalities (3.8) can be used to obtain the following expressions:
Thus the flow associated with the system (3.5) is dissipative and non-negatively invariant if S i +C i -e i0 > 0. In particular, the flow associated with the model equations (3.5) will eventually enter the set A and remains trapped in A for t 
Criteria for Persistence of HIV-1 Virions in the Chronic Phase
In this section, the criteria for the persistence of HIV-1 virions during the chronic phase will be derived. The definition of persistence and uniform persistence used in this section is similar to those elucidated in [36] [37] [38] .
The differential equation for the HIV-1 patho-physiodynamics during the clinical chronic phase is:
where S 3 is the reflux and repopulation rate of the plasma 
By solving (3.13) using Kamke's comparison technique, as discussed in [39, 40] , the following inequality is obtained:
where k is a positive constant.
In particular, the following theorems arise immediately:
Where H is a bounded positive number of subclinical value. As a consequence, the number of HIV-1 virions in the blood plasma of the AIDS patient during the chronic phase will exhibit persistence. The patient will not develop full-blown AIDS if the value of H is such that the patient does not experience immune system paralysis.
Theorem 3.3
where ε is a small positive number.
Then the blood plasma HIV-1 viral titre is negligibly subclinical and the AIDS patient has insignificant HIV-1 RNA copies in the blood plasma during the chronic phase. 
  e S
Then the number of HIV-1 virions in the blood plasma increases exponentially. The HIV-1 positive patient will develop full-blown AIDS. Consequently, the patient will ultimately loose immuno-competency and eventually die as a result of opportunistic infections.
Analyses of the Physiological Outcomes
The clinically significant equilibrium patho-physiological outcomes of HIV-1 dynamics during the acute and chronic phases will be analyzed in this section using the principles of linearized stability. The outcomes are called equilibrium points or rest points of the model equations. The analyses will involve five clinically interesting equilibrium outcomes labeled {E i : i =1, 2, 3, 4, 5}. 
Linearized Stability Analysis of Physiological Outcomes
The Hartman-Grobman theorem ( [40] ) can be used to investigate the local physiological stability of HIV-1 AIDS disease dynamics associated with the model equations, in the neighborhood of the physiological outcomes (equilibrium states). The mathematical model is nonlinear and as such it is difficult to obtain any meaningful quantitative criteria about the model. Fortunately, the HartmanGrobman theorem guarantees that the information contained in the linearized system and the information contained the nonlinear system are equivalent in the neighborhood of the rest points. The Jacobian matrix of linearization near any physiological outcome is denoted symbolically by
Criteria for annihilation of HIV-1 virions during the acute and chronic phases
The Jacobian matrix of linearization in the neighborhood of E2 is given by the following matrix: is local attractor. In particular, the HIV-1 infected CD4+ T cells and the HIV-1 virions in the blood plasma of the AIDS patient are temporarily annihilated during the acute and chronic phases in the absence of the pharmacotherapy.
Proof
The eigen-values of the Jacobian matrix (4.5) are associated with the equilibrium points E 2 are listed as follows:
Using the principles of linearized stability as discussed in [20] , it can be observed that the eigenvalues listed above are negative if the above conditions of (4.6a) hold.    When the conditions of Theorem 4.2 are violated, the HIV-1 positive person who is at the chronic stage of HIV infection will develop full-blown AIDS as described in [41] . On the other hand, if the conditions of Theorem 4.2 hold, the HIV-1 positive person will have stable chronic latency as described in [32] . Proof The eigen-values of the Jacobian matrix of linearization as shown in (4.5) imply that the equilibrium E 2 is a local attractor if the conditions in (4.9) hold. In particular, the condition (iii) of (4.9) is derived as follows. From (4.6b), we have the condition It is obvious that all of them are negative if (4.10) holds.
Hence the equilibrium E 2 is a local attractor.
The criteria for transient immune system paralysis during the acute and chronic phases of AIDS
One of the rest points corresponding the immune system paralysis during primary AIDS infection is E 3 . The Jacobian matrix of the linearization of the model equations in the neighborhood of E 3 is given as follows:
The application of the principles of linearized stability gives the following result:
Then the rest point E 3 is local attractor.
Proof Using the Jacobian matrix of linearization (4.11), the eigen-spectrum of associated with E 3 is given by: (   3  3  2  2  2  3  2  1  3  3  2  2  2 
Then the Routh-Hurwitz criterion as described in [40] can be used to show that The analysis of other rest points will be done in a future publication.
Global Stability Analysis of Physiological Outcomes
In this section, theoretical criteria will be presented for global stability of the clinically desirable physiological outcome
Consider space
The model equations (3.5) correspondingly reduce to the following: Hence, the sufficient criteria for the global asymptotic stability of E 2 are specified in the following theorem. x  Then the clinically desirable rest point E 2 is a global attractor.
The clinical implication of Theorem 4.6
Theorem 4.6 gives alternatively to two criterions which are otherwise different from Theorems 4.1-4.4, which characterizes the local stability of equilibrium point E 2 as a local attractor. Condition (ii) maintains that the CD4+ T cells concentration must greater than or equal to twice of the Michaelis-Menten constant for the autocrine process CD4+ T cell activation. Condition (iii) requires that the cytotoxic T lymphocytes concentration must greater than or equal to the Michaelis-Menten constant of the T lymphocytes activation by the CD4+ T cells. The AIDS patient will experience permanent annihilation of the infected CD4+ T cells and HIV-1 virions in the blood plasma if the patient's patho-physio-dynamics conforms to the conditions specified in the theorem.
Computer Simulation Results and Discussion
In this section, investigative computer simulations are performed under specific parametric configurations. It must be stated emphatically that The problem of parameter estimation in mathematical modeling of physiological systems is a nontrivial one. There is a quasi-uniqueness of patho-physio-dynamics of disease in the patient and as such no two persons have identical physiological parametric configurations for a given disease. These phenomena have been discussed in the publication [21] . Several techniques concerning parameter estimation have been discussed by many authors in [11, 13, 15-17, 26, 32, 42] .
Theorems 4.1-4.4, however, are based on equilibrium configurations of patho-physio-dynamics of AIDS. Thus, the techniques presented in the above references must be modified in order to obtain relevant estimates of the dynamical variables presented in this paper. In particular, in vitro and in vivo experiments as well as human biopsies from the peripheral blood of the AIDS patient are required in order to accurately determine most of the dynamical variables and constants of the model. Simulations based on equilibrium dynamics of AIDS using ACSL (Advanced Continuous Simulation Language) will be presented in a forthcoming paper.
Simulation results for hypothetical AIDS patient #1
The hypothetical patient #1 possesses a non-equilibrium patho-physio-dynamics parametric configuration P 1 presented in Table 1 . The HIV-1 dynamics in this patient represents the classic profile for the acute and clinically chronic phases of AIDS. The simulation results for patient #1 are exhibited in Fig. 1 . It can observed that the HIV-1 infected CD4+ T cells and the blood plasmas HIV-1 virions are completely eradicated in this patient without the use of anti-AIDS pharmaco-therapeutic drug protocols. In addition, patient #1 experiences immune system reconstitution as the uninfected CD4+ T cells repopulate and proliferate towards their pre-HIV-1 infection carrying capacities.
Simulation results for hypothetical AIDS patient #2
For this simulation, the hypothetical AIDS patient #2 is assigned the patho-physiological parameter configuration presented in Table 2 . As in the previous simulation, the configuration P2 does not depict an equilibrium configuration. The simulation results are exhibited in Fig. 2 . It can be observed that the patient does not have a clinically favorable prognosis. Because the disease has apparently progressed beyond the time point characterized as t p , which is defined as the threshold time for full-blown AIDS. As presented in Fig. 2 , the patient undergoes immune system paralysis in which the CD4+ T cells transiently destroyed. On the other hand, the cytotoxic activity of CD8+ T cells appears to be potent as observed in the eradication of the HIV-1 infected CD4+ T cells. Paradoxically the plasma HIV-1 viremia increases exponentially in the patient resulting in a more morbid AIDS outcome.
Simulation results for hypothetical AIDS patient #3
The patho-physiological parametric configuration of patient #3 is shown in Table 3 . It must be noted that the AIDS in this patient is in the acute phase and as such the simulation results span a time period lasting up to one year. The results of the simulation are in Figure 3 . This is a nonequilibrium AIDS configuration simulation as it is evident by the simulation time profile. The simulation results show that at the end of the acute phase, the AIDS patient experiences annihilation of uninfected CD4+ T cells. In addition, the HIV-1 specific CD8+ T cells eradicate successfully the HIV-1 infected CD4+ T cells. Unfortunately the immune system paralysis, which occurs as a consequence of the low CD4+ T cell number density, eventually leads to an exponential increase of the blood plasma HIV-1 viremia. This simulation represents an unfavorable AIDS outcome during the acute phase.
Simulation results for hypothetical AIDS patient #4
The simulation results for hypothetical patient #4 are exhibited in Fig. 4 . These simulation results are based on the patho-physiological parametric configuration P4. In this patient the AIDS disease progresses from the acute phase into a 6 year clinically chronic phase before the development of full-blown AIDS.
Simulation results for hypothetical AIDS patient #5
This scenario represents a relatively favorable progression of AIDS in hypothetical patient #5. The data for the simulation results are given in Table 5 
Simulation results for hypothetical AIDS patient #6
The patho-physiological configuration of hypothetical patient #6 is given in Table 6 . The simulation results depict an AIDS scenario which progresses from the acute phase through a relatively short chronic phase and heading towards the development of full-blown AIDS, as shown in Figure 6 . It can be observed also that from the time period between 0 to 4 years the patient has sufficient immuno-competency as it is evident in the relatively higher dynamic number density of the CD4+ T cells and the HIV-1 specific CD8+ T cells as compared to the low dynamic number density of the HIV-1 infected CD4+ T cells and the blood plasma HIV-1 virions. Beyond the period of 6 years, then blood plasma HIV-1 virion and the HIV-1 infected CD4+ T cells number densities begin to rise as the patient heads towards the development of full-blown AIDS. 
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